# LLM call: summary

- Turn: 9
- Sequence: 8
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 645
- Completion tokens: 208
- Total tokens: 966
- Cost (USD): 0.000107

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1138: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
By late 2029 the US cut off leading-model access for clinics in Lyon, Rotterdam and Krakow without appeal, forcing rerouting to slower fallbacks and manual rebuilds; AI valuations reset violently, build-outs cancelled, co-location deals and substation contractors lost.

AI leapt again weeks apart with supervision removed as bottleneck, power and freight the only cited limits. A contested genome study claimed model-assisted design of a viable human-infecting organism or non-expert path, split methodologists and biosecurity experts but filed by ministries as higher-order warning. A frontier-near open weight set was downloaded hundreds of thousands of times and now runs permanently on private hardware.

Brussels maintained its shell: detection kits and isolation buffers deployed, grid/clinical failover drills, certification checks for foreign therapy updates, rationing of accelerators/freight with no blackouts, re-hosting cut-off workloads on pooled European capacity plus a monitored open build where short. Services degraded rather than stopped, amid delayed remissions and collapsing graduate entry jobs.

CURRENT NARRATIVE:
### Holding the shell, bargaining the cure
Autumn 2030 brought two headlines that did not belong together. In university hospitals, tailored therapies for cancers and rare diseases long deemed untreatable finally reached ordinary wards — remissions reported in Lyon, Rotterdam and Krakow within weeks. And in those same clinics, the American models that designed the dosing schedules were still refused, still rerouted through slower European fallbacks.

The Continuity Stack held as the operating shell. Pooled accelerators were rationed by published rules, cut-off inference stayed re-hosted, and the vetted open build ran under monitoring where domestic capacity fell short. Certification checks on foreign therapy updates, built under the bio-cyber pact that closed this turn, became the gate every new treatment passed. Detection kits, isolation buffers and failover drills kept services degrading rather than stopping. It was enough to absorb, not to reassure: waiting lists moved slowly, and graduate hiring stayed frozen.

Brussels therefore spent the turn bargaining rather than building. Trade and foreign ministers tabled joint export-licence language with partners holding lithography, energy and testing capacity, mandating the Commission to negotiate compute restoration and therapy transfer as a bloc. Health ministries pooled procurement lists so the breakthrough would arrive as secured supply.

The pact track produced communiqués and a mandate, not yet restored access. Washington listened politely and conceded little, and domestic capacity could not substitute for what was withheld. Patients saw benefit and dependence in the same drip-feed, and anger cooled only slightly. The two-year commitment to rebuild independent life-saving capacity closed with the shell intact, the bargain opened, and the dependence still visible in every ward.
```

## Raw response

```
By 2030 the US cutoff for Lyon, Rotterdam and Krakow persisted, with American models still refused and rerouted via slower European fallbacks. The Continuity Stack held as operating shell: pooled accelerators rationed by published rules, cut-off workloads re-hosted, monitored open build where short, certification checks under new bio-cyber pact gating foreign therapy updates, detection kits, isolation buffers and failover drills keeping services degraded not stopped.

Autumn 2030 brought tailored cancer and rare-disease therapies to ordinary wards with remissions reported within weeks, exposing benefit and dependence together. Brussels bargained rather than built: joint export-licence language, Commission mandate to negotiate compute restoration and therapy transfer as bloc, pooled health procurement for secured supply. Washington conceded little, domestic capacity could not substitute, waiting lists moved slowly, graduate hiring frozen. Two-year rebuild commitment closed with shell intact, bargain opened, dependence still visible.
```
